UBS Group
INCR

UBS Group’s Intercure INCR Stock Holding History

UBS Group’s Portfolio INCR Stock Details INCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-591
Closed -$969 – 10834
2025
Q3 		$969 Sell
591
-7,648
-93% -$11.9K ﹤0.01% 9476
2025
Q2 		$12.1K Buy
+8,239
New +$12.2K ﹤0.01% 8751
2024
Q4 		– Sell
-44
Closed -$88 – 10152
2024
Q3 		$88 Buy
+44
New +$92 ﹤0.01% 9173
2024
Q2 		– Sell
-4,508
Closed -$12.2K – 9776
2024
Q1 		$12.2K Sell
4,508
-5,390
-54% -$9.18K ﹤0.01% 7145
2023
Q4 		$12.8K Buy
9,898
+9,193
+1,304% +$11.2K ﹤0.01% 7338
2023
Q3 		$1.11K Buy
+705
New +$1.13K ﹤0.01% 8099
2023
Q2 		– Sell
-1,698
Closed -$3.46K – 9238
2023
Q1 		$3.46K Sell
1,698
-268
-14% -$806 ﹤0.01% 8318
2022
Q4 		$6.49K Sell
1,966
-4,371
-69% -$20.3K ﹤0.01% 9027
2022
Q3 		$29K Buy
6,337
+4,371
+222% +$23.8K ﹤0.01% 6919
2022
Q2 		$11K Sell
1,966
-8,406
-81% -$53.1K ﹤0.01% 7812
2022
Q1 		$74K Sell
10,372
-75,728
-88% -$501K ﹤0.01% 6121
2021
Q4 		$558K Sell
86,100
-28,120
-25% -$202K ﹤0.01% 4895
2021
Q3 		$792K Buy
+114,220
New +$820K ﹤0.01% 4380

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return

UBS Group's INCR Position: Q4 2025 in Review

UBS Group sold out of Intercure (INCR) in Q4 2025, closing a stake of 591 shares — an estimated $969 sold.

UBS Group first reported a position in INCR in Q3 2021 and held it in 13 quarters. The position peaked at $792K in Q3 2021. 19 funds tracked by Wall St. Rank hold INCR as of Q4 2025.

  • UBS Group reported no remaining Intercure position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 591 Intercure shares in Q4 2025, an estimated $969.
  • UBS Group first reported a position in Intercure in Q3 2021 and held it in 13 quarters.
  • UBS Group's Intercure position peaked at $792K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Intercure as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.